Skip to main content
. 2021 Nov 26;9(12):1771. doi: 10.3390/biomedicines9121771

Table 1.

Baseline demography of five pathology types divided into malignant and benign groups.

Pathological Types
Malignant Group
(n = 421)
Benign Group (n = 391)
PTC FVPTC FTC HCC Benign p-Value
Number of patients 214 114 70 23 391
Age (years), mean (SD) 47.36 ± 13.70 44.90 ± 15.12 46.61 ± 17.10 51.17 ± 15.62 54.18 ± 13.15 <0.0001
Sex (n, %)
Male 53 (25) 28 (25) 15 (21) 4 (17) 80 (20) 0.6985
Female 161 (75) 86 (75) 55 (79) 19 (83) 311 (80)
Number of US images 470 215 131 38 937
Number of cropped images 533 272 175 53 1275
Location (n, %)
Left 88 (41.12) 52 (45.61) 39 (55.71) 13 (56.52) 143 (36.57) 0.0017
Right 109 (50.93) 57 (50.00) 27 (38.57) 10 (43.48) 192 (49.10)
Both (Left + Right) 11 (5.15) 4 (3.51) 1 (1.43) 0 (0.00) 47 (12.03)
Isthmus 6 (2.80) 1 (0.88) 3 (4.29) 0 (0.00) 9 (2.30)
Ultrasound brands (%)
Aloka 3.93 2.46 6.67 0.00 7.57 <0.0001
GE Healthcare 37.12 62.30 64.01 78.26 45.87
Hitachi 7.42 2.46 1.33 0.00 7.34
Philips 4.37 0.82 8.00 8.70 2.06
Siemens 28.82 10.66 5.33 8.70 18.81
Toshiba 17.90 16.39 13.33 4.34 18.12
Others 0.44 4.91 1.33 0.00 0.23

Continuous data are expressed as the mean and standard deviation (SD); categorical data are expressed as a percentage (%). Papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), follicular variant of papillary thyroid carcinoma (FVPTC), Hürthle cell carcinoma (HCC), ultrasound (US).